WebMay 2, 2024 · Prospective, three-stage, single arm, multi-site, clinical investigation evaluating the safety and efficacy of the reSept ASD Occluder in treating clinically significant … WebMay 4, 2024 · Joe DiMaggio Children's Hospital recently announced the successful treatment of a patient with atrial septal defects (ASD), or opening defect in the wall of the heart that separates
atHeart Medical Receives FDA Approval for the Second Phase of …
WebApr 20, 2024 · The company's first product, the reSept ASD Occluder, is the first occluder with a metal-free, bioresorbable frame. The novel implant is poised to overcome the … WebFeb 8, 2024 · The company stated that reSept ASD occluder aims to address the limitations of occluders with metallic frames that can place patients at risk of complications … data phone cable
First Five Patients Successfully Treated with atHeart Medical
WebJul 1, 2024 · PCL ASD occluder. The PCL ASD biodegradable occluder consists of eight PCL spokes fabricated by microinjection molding and PLGA/collagen nanofibrous membranes prepared by electrospinning (Fig. 3 g). The membranes and PCL spokes are integrated by hot-spot welding. The biodegradable occluder is cable-controlled and has a self-locking … WebApr 26, 2024 · AtHeart Medical has begun an investigational device exemption trial for its reSept atrial septal defect (ASD) occluder. The first occluder that features a metal-free bioresorbable frame, the device is designed to overcome the limitations of current occluders by reducing the risk of complications associated with the long-term presence of metal in … WebMay 4, 2024 · The reSept ASD Occluder is the first transcatheter ASD occluder with a metal-free frame. It is an investigational medical device manufactured by atHeart Medical. martin\u0027s grill charlottesville